Document Detail

FGF-R3 and OPG expression in patient with multiple myeloma following systemic sclerosis: case report and review of the literature.
MedLine Citation:
PMID:  21207214     Owner:  NLM     Status:  MEDLINE    
The presence of multiple myeloma (MM) in a patient with systemic sclerosis is a rare and unusual occurrence with unclear significance. We report the case of a 55-year-old woman with a 20-year history of systemic sclerosis, who subsequently presented with clinical stage IIIA IgG-λ MM. The systemic sclerosis was diagnosed and treated in 1988 with D: -penicillamine and methotrexate. Twenty years later, in December 2008, she presented with symptoms of Raynaud's phenomenon and intense facial pruritus. Immunoelectrophoresis confirmed the presence of a IgG-λ paraprotein (71.90 g/l) and Bence Jones proteinuria of the lambda light chains. Bone marrow histology revealed infiltrates of plasmocytes and lymphoplasmocytes which were on immunohistochemistry CD38+, FGF-R3+ and OPG+. An extensive X-ray skeletal survey did not show any osteolytic lesions or fractures. The patient was treated according to the CTD protocol (cyclophosphamide, thalidomide, and dexamethasone) which was effective against the myeloma as well as the systemic sclerosis and patient achieved complete remission.
Milica Čolović; Vladimir Jurisic; Jelena Bila; Natasa Čolović; Vuk Palibrk
Related Documents :
20919664 - Does a concomitant cox-maze procedure improve survival in atrial fibrillation?
11203914 - Use of an existing post to rerestore an endodontically treated tooth with a new post-an...
7269184 - Assessment of oviduct potency in the cow.
3981714 - Pubectomy in urological surgery.
17775414 - Yale natural radiocarbon measurements ii.
19034984 - Concomitant gastric adenocarcinoma and stromal tumor in a woman with polymyalgia rheuma...
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2011-01-05
Journal Detail:
Title:  International journal of hematology     Volume:  93     ISSN:  1865-3774     ISO Abbreviation:  Int. J. Hematol.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-02-17     Completed Date:  2011-06-09     Revised Date:  2012-06-05    
Medline Journal Info:
Nlm Unique ID:  9111627     Medline TA:  Int J Hematol     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  228-31     Citation Subset:  IM    
Institute of Hematology, Clinical Center of Serbia, Koste Todorovića 2, Belgrade, Serbia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bone Marrow / metabolism,  pathology
Middle Aged
Multiple Myeloma / complications*,  metabolism*,  pathology
Osteoprotegerin / metabolism*
Receptor, Fibroblast Growth Factor, Type 3 / metabolism*
Scleroderma, Systemic / complications*
Reg. No./Substance:
0/Osteoprotegerin; 0/TNFRSF11B protein, human; EC protein, human; EC, Fibroblast Growth Factor, Type 3

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Quality of long-term cryopreserved umbilical cord blood units for hematopoietic cell transplantation...
Next Document:  Down-regulating the expression of IL-3R? interfered with the proliferation, not differentiation in N...